The work described within this thesis explores the use of HPLC coupled with ICPMS
and ESI-MS in order to develop novel methods which overcome specific
analytical challenges in the pharmaceutical industry.
A membrane desolvation interface has been evaluated for coupling high
performance liquid chromatography (HPLC) with inductively coupled plasma mass
spectrometry (ICP-MS). Desolvation of the sample prior to reaching the plasma
was shown to facilitate a versatile coupling of the two instrumental techniques,
enabling chromatographic eluents containing up to 100 % organic to be used. This
interface also allowed gradient elution to be used with ICP-MS.
Tris(2,4,6-trimethoxyphenyl)phosphonium propylamine bromide (TMPP) was used
for the derivatisation of maleic, fumaric, sorbic and salicylic acids to facilitate
determination by HPLC-electrospray ionisation tandem mass spectrometry (ESIMS/
MS) in positive ion mode. Improvements in detection limits post-derivatisation
were achieved, and this method was successfully used for the determination of
sorbic acid in a sample of Panadolâ„¢.
HPLC coupled with sector field inductively coupled plasma mass spectrometry
(SF-ICP-MS) has been used for the determination of maleic, sorbic and fumaric
acids after derivatisation with TMPP. This allowed 31P+ selective detection to be
performed for these compounds, which are normally undetectable by ICP-MS.
Optimal reagent conditions for the derivatisation of 0.1 mM maleic acid were: 1
mM TMPP; 10 mM 2-chloro-1-methylpyridinium iodide (CMPI); 11 mM
triethylamine. The efficiency of the derivatisation reaction was estimated to be
between 10-20%. Detection limits, estimated as 3 times baseline noise, were
0.046 nmol for TMPP and 0.25 nmol for derivatised maleic acid, for a 5 f.JL
injection.
Following on from this, a novel derivatising reagent, tris(3,5-dibromo-2,4,6-
trimethoxyphenyl) phosphonium propylamine bromide (BrTMPP), was synthesised
and subsequently characterised by proton NMR spectroscopy and ESI-MS. This
was utilised to derivatise maleic acid, with a 9-fold increase in sensitivity gained
when analysed by bromine selective detection as apposed to phosphorus
selective ICP-MS. This derivatising reagent (BrTMPP) was also utilised to
determine the degree of phosphorylation on phosphorylated peptides. A
phosphorus containing carboxylic acid was successfully derivatised and the
correct Br:P ratio was determined for this compound by ICP-MS. However,
phosphorylated peptides were not successfully derivatised by BrTMPP. A
combination of UV and phosphorus selective ICP-MS was also used to distinguish
between phosphorylated and un-phosphorylated peptides after HPLC separation.
Date of Award | 2005 |
---|
Original language | English |
---|
Awarding Institution | |
---|
ANALYSIS OF PHARMACEUTICALS AND BIOMOLECULES USING HPLC COUPLED TO ICP-MS AND ESI-MS
Cartwright, A. J. (Author). 2005
Student thesis: PhD